<?xml version="1.0" encoding="utf-8" ?>

<XML>
  <JOURNAL>   
    <YEAR>2025</YEAR>
    <VOL>17</VOL>
    <NO>3</NO>
    <MOSALSAL>30065</MOSALSAL>
    <PAGE_NO>75</PAGE_NO>  
    <ARTICLES>

<ARTICLE>
    <TitleE>When Classrooms Become Battlegrounds: The Assault on Iranian Science</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;When Classrooms Become Battlegrounds: The Assault on Iranian Science&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;In a shocking escalation, Iran was recently targeted by the Israeli regime in a military operation that, among its many atrocities, aimed to undermine the nation&amp;#39;s scientific and intellectual infrastructure. Alarming reports indicate that key figures in Iran&amp;rsquo;s academic community, especially in fields like physics and medical sciences were directly attacked. Universities and classrooms were struck by missiles and drones. Several academics were assassinated along with their families, including women and children. &lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;During the brutal 12-day attack by the Zionist regime on Iran, Shahid Beheshti University and many of its professors, especially in the physics department, were directly attacked with missiles and drones in the classroom and at home, which is a rare incident in the current world.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;Tragically, &lt;strong&gt;six medical doctors and eighteen healthcare workers&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;were martyred, including&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;two pediatricians and gynecologists&lt;/strong&gt; who lost their lives alongside their young children. Beyond the irreparable human loss, these attacks caused severe psychological trauma. Students preparing for national and final exams experienced acute distress, and many along with their families are now dealing with Post-Traumatic Stress Disorder (PTSD) (1,2).&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;In light of this devastating assault, we must reflect on the broader implications for scientific progress, particularly in the realm of basic sciences (3). Two opposing perspectives emerge:&lt;/span&gt;&lt;/p&gt;

&lt;ol&gt;
	&lt;li style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;Support for Basic Sciences is Crucial:&lt;/strong&gt; Fundamental research, especially when translatable into clinical or applied outcomes, is the backbone of innovation. It fuels optimism, confidence, and problem-solving within academic communities. Supporting basic sciences fosters resilience in both students and faculty, helping societies confront and overcome crises.&lt;/span&gt;&lt;/li&gt;
	&lt;li style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;Neglecting Science is Self-Sabotage:&lt;/strong&gt; A narrow, short-sighted approach to funding where research budgets are cut due to economic pressures risks compounding the damage inflicted by external attacks. When scientific development is deprioritized, the consequences for national resilience and innovation are even more severe than the physical destruction wrought by missiles.&lt;/span&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;Unfortunately, the challenges Iranian scientists face extend beyond the battlefield. As an editor, I am increasingly concerned by the unscientific treatment of Iranian researchers by international publishers. In recent months, many submissions have been rejected on non-academic grounds, reflecting a troubling politicization of global science. This practice, which echoes earlier directives by U.S. authorities to restrict Iranian authors, is a clear departure from the ideals of impartial and collaborative scientific inquiry (4). Indeed, science should never be a casualty of politics.&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;Yet, despite these adversities, Iran&amp;rsquo;s scientific community endures. As affirmed in the Holy Qur&amp;rsquo;an, &lt;em&gt;&amp;ldquo;Indeed, Allah is with those who are patient.&amp;rdquo;&lt;/em&gt; In the face of oppression, our scientists continue to pursue knowledge, serve humanity, and inspire hope.&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>158</FPAGE>
            <TPAGE>158</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Shahin</Name>
<MidName></MidName>
<Family>Akhondzadeh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Editorial</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70623.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Jafari P, Ghanizadeh A, Akhondzadeh S, Mohammadi MR. Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder. Qual Life Res 2011;20(1):31-6. ##Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(1):145-9. ##Akhondzadeh S. The Need for Serious Support for Basic Medical Science in Iran. Avicenna J Med Biotechnol 2024;16(3):136. ##Akhondzadeh S. US Editors and Reviewers can no Longer Handle Submissions by Authors Employed by the Government of Iran: Is it Fair and Logical? Avicenna J Med Biotechnol 2013 Oct;5(4):203.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Production and Characterization of IgY Polyclonal Antibodies Specific to Human  Interleukin-6 and Their Neutralization Potential for Anti-inflammatory Responses </TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Interleukin-6 plays an essential role in cytokine storm and cytokine release syndrome, which occur in response to pathogen infection or tissue injury and are associated with severe symptoms. Neutralizing IL-6 can help reduce symptom severity. Chicken eggs serve as an excellent alternative antibody source compared to mammalian serum. The immunoglobulin Y (IgY) in the chicken&amp;rsquo;s blood is transferred to and deposited within the egg yolk in large amounts. Several IgY products have been developed for therapeutic applications in various diseases. This study focuses on producing anti-human IL-6 (IL-6) IgY antibodies to support therapeutic advancements. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Anti-IL-6 IgY was generated by immunizing three hens with recombinant IL-6 protein mixed with alum adjuvant, immunized four times at three-week intervals. Then, IgY was extracted from egg yolks. The specificity of IgY was determined by Western blot. The neutralizing activity against secreted IL-6 was demonstrated by Human Coronavirus OC43 (HCoV-OC43)-infected cells and Lipopolysaccharide (LPS)-stimulated human lung fibroblast MRC-5 cells.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The specific anti-IL-6 was detected starting from day 10 to day 90 after immunization. The average yield of total IgY was 17.97&amp;plusmn;15.66 &lt;em&gt;mg&lt;/em&gt; per egg. The extracted anti-IL6 IgY antibody exhibited efficient neutralizing effects against secreted IL-6 in the HCoV-OC43-infected or LPS-stimulated cells in a dose-dependent manner. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; This study highlights the ease of production and the satisfactory yield of anti-IL-6 IgY derived from chicken eggs. The antibody demonstrates an &lt;em&gt;in vitro&lt;/em&gt; inhibitory effect on IL-6, with potential applications in therapeutic development.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>159</FPAGE>
            <TPAGE>166</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Pacharaporn</Name>
<MidName></MidName>
<Family>Khumpim</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Institute of Molecular Biosciences, Mahidol University, Salaya, PhutthamonthonFaculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon</Organization>
</Organizations>
<Universities>
<University>Institute of Molecular Biosciences, Mahidol University, Salaya, PhutthamonthonFaculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon</University>
</Universities>
<Countries>
<Country>ThailandThailand</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Charin</Name>
<MidName></MidName>
<Family>Thawornkuno</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Tropical Medicine, Mahidol University, Ratchathewi</Organization>
</Organizations>
<Universities>
<University>Faculty of Tropical Medicine, Mahidol University, Ratchathewi</University>
</Universities>
<Countries>
<Country>Thailand</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Surapon</Name>
<MidName></MidName>
<Family>Piboonpocanun</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Institute of Molecular Biosciences, Mahidol University, Salaya, Phutthamonthon</Organization>
</Organizations>
<Universities>
<University>Institute of Molecular Biosciences, Mahidol University, Salaya, Phutthamonthon</University>
</Universities>
<Countries>
<Country>Thailand</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Wongsakorn</Name>
<MidName></MidName>
<Family>Wongwadhunyoo</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon</Organization>
</Organizations>
<Universities>
<University>Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon</University>
</Universities>
<Countries>
<Country>Thailand</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Promsin</Name>
<MidName></MidName>
<Family>Masrinoul</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Chickens</KeyText></KEYWORD><KEYWORD><KeyText>Coronavirus</KeyText></KEYWORD><KEYWORD><KeyText>Egg yolks</KeyText></KEYWORD><KEYWORD><KeyText>IgY</KeyText></KEYWORD><KEYWORD><KeyText>Interleukin-6</KeyText></KEYWORD><KEYWORD><KeyText>Lipopolysaccharides</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70615.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Khong WX, Foo DGW, Trasti SL, Tan EL, Alonso S. Sustained high levels of interleukin-6 contribute to the pathogenesis of Enterovirus 71 in a neonate mouse model. J Virol 2011;85(7):3067-76.##Zhang SY, Xu MY, Xu HM, Li XJ, Ding SJ, Wang XJ, et al. Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children. Medicine (Baltimore) 2015;94(27):e1137. ##Talwar D, Kumar S, Acharya S, Raisinghani N, Madaan S, Hulkoti V, et al. Interleukin 6 and Its Correlation with COVID-19 in Terms of Outcomes in an Intensive Care Unit of a Rural Hospital: A Cross-sectional Study. Indian J Crit Care Med 2022;26(1):39-42.##Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74(5):1704-10.##Molano Franco D, Arevalo-Rodriguez I, Roqu&#233; I Figuls M, Montero Oleas NG, Nuvials X, Zamora J. Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults. Cochrane Database Syst Rev 2019;4(4):CD011811. ##Kishimoto T. IL-6: from its discovery to clinical applications. Inter Immnol 2010;22(5):347-52. ##Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 2014;6:a016295. ##Schaper F, Rose-John S. Interleukin-6: Biology, signaling and strategies of blockade. Cytokine Growth Factor Rev 2015;26(5):475-87. ##Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV. The role of Interleukin 6 during viral infections. Front Microbiol 2019;10:1057.##Reza Elahi R, Karami P, Heidary AH, Esmaeilzadeh A. An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). Int Immunopharmacol 2022;105:108536.##Barati B, Ebrahimi F, Nazarian S. Egg yolk antibodies for disease prevention. J Bacteriol Mycol Open Access 2016;3(2):219-22.##Suthaus J, Adam N, Gr&#246;tzinger J, Scheller J, Rose-John S. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.  Eur J Cell Biol 2011;90:495-504. ##Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents 2020;55:105954. ##Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes IB, et al. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Ann Rheum Dis 2023;82(6):773-87. ##Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther 2014;141(2):125-39. ##Pelletier JP, Mukhtar F. Passive monoclonal and polyclonal antibody therapies. InImmunologic Concepts in Transfusion Medicine 2020 Jan 1 (pp. 251-348). Elsevier.##Kumaran T. Production of IgY antibodies from egg yolk of immunized chickens. Advancements Bioequiv Avilab 2018;1(1):3-4.##da Silva WD, Tambourgi DV. IgY: A promising antibody for use in immunodiagnostic and in immunotherapy. Vet Immunol Immunopathol 2010;135(3-4):173-80. ##Amro WA, Al-Qaisi W, Al-Razem F. Production and purification of IgY antibodies from chicken egg yolk. J Genet Eng Biotechnol 2018;16:99-103.##Bizanov G. IgY extraction and purification from chicken egg yolk. Journal of the Hellenic Veterinary Medical Society 2017;68(3):265-72.##Karachaliou C, Vassilakopoulou V, Livaniou E. IgY technology: methods for developing and evaluating avian immunoglobulins for in vitro detection of biomolecules. World J Methodol 2021;11(5):243-62. ##Nilsson E, St&#229;lberg J, Larsson A. IgY stability in eggs stored at room temperature or at + 4 ̊C. Br Poult Sci 2012;53:42-6. ##Zhang WW. The use of gene specific IgY antibodies for drug target discovery. Drug Discov Today 2003;8(8):364-71. ##Michael A, Meenatchisundaram S, Parameswari G, Subbraj T, Selvakumaran R, Ramalingam S. Chicken egg yolk antibodies (IgY) as an alternative to mammalian antibodies. Indian J Sci Technol 2010 Apr;3(4):468-74.##Ramakrishnan MA. Determination of 50% endpoint titer using a simple formula. World J Virol 2016;5(2):85-6. ##Woolley JA, Landon J. Comparison of antibody production to human interleukin-6 (IL-6) by sheep and chickens. J Immunol Methods 1995;178(2):253-65. ##Redwan EM, Aljadawi AA, Uversky VN. Simple and efficient protocol for immunoglobulin Y purification from chicken egg yolk. Poult Sci 2021;100(3):100956. ##Idar I, Yusuf M, Al Anshori J, Subroto T. Purification of IgY Anti-SARS-CoV-2-Chicken Nucleocapsid and Elimination of Its Low-temperature Storage-induced Aggregates. Trends in Sciences. 2024 Mar 20;21(5):7649.##Rose-John S. Interleukin-6 Family Cytokines. Cold Spring Harb Perspect Biol 2018;10(2):a028415. ##McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med 2020;202(6):812-21. ##Tasoudis PT, Arvaniti CK, Adamou AT, Belios I, Stone JH, Horick N, et al. Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials. Eur J Intern Med 2022;101:41-48. ##Hsu HY, Yang CW, Lee YZ, Lin YL, Chang SY, Yang RB, et al. Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2. Front Pharmacol 2021;12:706901. ##Beurel E, Jope RS. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. J Neuroinflammation 2009;6:9. ##Ma L, Zhang H, Yin YL, Guo WZ, Ma YQ, Wang YB, et al. Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine 2016;88:126-35. ##Hamilton FW, Thomas M, Arnold D, Palmer T, Moran E, Mentzer AJ, et al. Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study. PLoS Med 2023;20(1):e1004174. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Characterization and Evaluation of the Anti-proliferative Activity and Hypersensitivity  of L-Asparaginase from Trichosporon asahii Isolate ChL11 and Candida palmioleophila Isolate JK12</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; L-Asparaginase is a crucial enzyme to treat Acute Lymphoblastic Leukemia (ALL), as it depletes L-asparagine, an essential amino acid for cancer cell survival. However, its clinical use is often restricted due to hypersensitivity reactions. This study examined the anti-proliferative effects and hypersensitivity of fungal L-asparaginases (L-ASNases) from &lt;em&gt;Trichosporon asahii&lt;/em&gt; &lt;em&gt;isolate ChL11&lt;/em&gt; (TaIChL11 L-ASNase) and &lt;em&gt;Candida palmioleophila&lt;/em&gt; &lt;em&gt;isolate JK12&lt;/em&gt; (CpIJK12 L-ASNase). &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The enzymes were produced and purified through ammonium sulfate precipitation, dialysis, and Sephadex G-100 chromatography, and tested on leukemia cells and BALB/c female mice to assess immune responses. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; TaIChL11 L-ASNase had a molecular weight of 40 &lt;em&gt;kDa&lt;/em&gt;, Michaelis constant (K&lt;sub&gt;M&lt;/sub&gt;) of 1.66&amp;times;10⁻&amp;sup2; &lt;em&gt;mM&lt;/em&gt;, and V&lt;sub&gt;max&lt;/sub&gt; of 37.23 &lt;em&gt;mM/min&lt;/em&gt;, while CpIJK12 L-ASNase had a molecular weight of 135 &lt;em&gt;kDa&lt;/em&gt;, K&lt;sub&gt;M&lt;/sub&gt; of 2.3&amp;times;10⁻&amp;sup2; &lt;em&gt;mM&lt;/em&gt;, and V&lt;sub&gt;max&lt;/sub&gt; of 14.03 &lt;em&gt;mM/min&lt;/em&gt;. Both enzymes exhibited significant anti-proliferative effects against CCRF-CEM cancer cells, with half-maximal inhibitory concentration (IC&lt;sub&gt;50&lt;/sub&gt;) values of 2.74 &lt;em&gt;U/ml&lt;/em&gt; for TaIChL11 L-ASNase and 3.30 &lt;em&gt;U/ml&lt;/em&gt; for CpIJK12 L-ASNase after 48 &lt;em&gt;hr&lt;/em&gt;, improving further after 72 &lt;em&gt;hr&lt;/em&gt;. They also showed low cytotoxicity toward normal Vero E6 cells. &lt;em&gt;in vivo&lt;/em&gt; studies demonstrated that TaIChL11 ASNase-treated mice had significantly lower Immunoglobulin (Ig) G levels than those treated with commercial L-ASNase from &lt;em&gt;Erwinia chrysanthemi&lt;/em&gt; (Owenism) (p&amp;lt;0.005), with no detectable IgE response. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; These findings indicate that fungal L-ASNases, particularly TaIChL11 ASNase, with lower L-glutaminase activity and a favorable safety profile, could be promising alternatives to bacterial L-ASNases, potentially enhancing ALL treatment with fewer side effects.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>167</FPAGE>
            <TPAGE>179</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Tekeba</Name>
<MidName></MidName>
<Family>Sisay </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Medical Biotechnology, Institute of Biotechnology, University of Gondar</Organization>
</Organizations>
<Universities>
<University>Department of Medical Biotechnology, Institute of Biotechnology, University of Gondar</University>
</Universities>
<Countries>
<Country>Ethiopia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Naomi</Name>
<MidName></MidName>
<Family>Maina</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology and Innovations (PAUSTI)Biochemistry Department, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, </Organization>
</Organizations>
<Universities>
<University>Department of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology and Innovations (PAUSTI)Biochemistry Department, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, </University>
</Universities>
<Countries>
<Country>Kenya Kenya </Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Victor</Name>
<MidName></MidName>
<Family>Mobegi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biochemistry, Faculty of Science and Technology, University of Nairobi</Organization>
</Organizations>
<Universities>
<University>Department of Biochemistry, Faculty of Science and Technology, University of Nairobi</University>
</Universities>
<Countries>
<Country>Kenya </Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sabina</Name>
<MidName></MidName>
<Family>Wachira</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Kenya Medical Research Institute, Center for Traditional Medicine and Drug Research</Organization>
</Organizations>
<Universities>
<University>Kenya Medical Research Institute, Center for Traditional Medicine and Drug Research</University>
</Universities>
<Countries>
<Country>Kenya </Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Ammonium sulfate</KeyText></KEYWORD><KEYWORD><KeyText>Asparaginase</KeyText></KEYWORD><KEYWORD><KeyText>Asparagine</KeyText></KEYWORD><KEYWORD><KeyText>Dickeya chrysanthemi</KeyText></KEYWORD><KEYWORD><KeyText>Glutaminase</KeyText></KEYWORD><KEYWORD><KeyText>Sephadex</KeyText></KEYWORD><KEYWORD><KeyText>Trichosporon asahii</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70616.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Brumano LP, da Silva FVS, Costa-Silva TA, Apolin&#225;rio AC, Santos JHPM, Kleingesinds EK, et al. Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles. Front Bioeng Biotechnol 2019 Jan 10;6:212. ##Jiang J, Batra S, Zhang J. Asparagine: A Metabolite to Be Targeted in Cancers. Metabolites 2021 Jun 19;11(6):402. ##Van Trimpont M, Peeters E, De Visser Y, Schalk AM, Mondelaers V, De Moerloose B, et al. Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy. Cancers (Basel) 2022 Feb 11;14(4):902. ##Ghasemian A, Al-Marzoqi AH, Al-Abodi HR, Alghanimi YK, Kadhum SA, Shokouhi Mostafavi SK, et al. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives. J Cell Physiol 2019 Nov;234(11):19271-9. ##Doriya K, Kumar DS. Isolation and screening of L-asparaginase free of glutaminase and urease from fungal sp. 3 Biotech 2016 Dec;6(2):239. ##Lopes AM, Oliveira-Nascimento L, Ribeiro A, Tairum CA Jr, Breyer CA, Oliveira MA, et al. Therapeutic l-asparaginase: upstream, downstream and beyond. Crit Rev Biotechnol. 2017 Feb;37(1):82-99. ##Fonseca MHG, Fi&#250;za TDS, Morais SB, Souza TACB, Trevizani R. Circumventing the side effects of L-asparaginase. Biomed Pharmacother 2021 Jul;139:111616. ##El-Bessoumy AA, Sarhan M, Mansour J. Production, isolation, and purification of L-asparaginase from Pseudomonas aeruginosa 50071 using solid-state fermentation. J Biochem Mol Biol 2004 Jul 31;37(4):387-93. ##Sarquis MI, Oliveira EM, Santos AS, Costa GL. Production of L-asparaginase by filamentous fungi. Mem Inst Oswaldo Cruz 2004 Aug;99(5):489-92.##Gupta N, Dash SJ, Basak UC. L-asparaginases from fungi of Bhitarkanika mangrove ecosystem. AsPac J. Mol Biol Biotech 2009;17(1):27-30.##Rath J, Dangar TK. Osmotolerant microbial resources of saline ecologies of India: dynamics and potential. In: Bacterial Diversity in Sustainable Agriculture 2014 Sep 5 (pp. 265-303). Cham: Springer International Publishing.##Momeni V, Alemzadeh I, Vosoughi M. Enhancement of L-asparaginase production by Candida utilis in a 13l fermenter and its purification. Int J Eng 2015 Aug 1;28(8):1134-9.##Cachumba JJ, Antunes FA, Peres GF, Brumano LP, Santos JC, Da Silva SS. Current applications and different approaches for microbial l-asparaginase production. Braz J Microbiol 2016 Dec;47 Suppl 1(Suppl 1):77-85.  ##Ashok A, Doriya K, Rao JV, Qureshi A, Tiwari AK, Kumar DS. Microbes Producing L-Asparaginase free of Glutaminase and Urease isolated from Extreme Locations of Antarctic Soil and Moss. Sci Rep. 2019 Feb 5;9(1):1423. ##Hatamzadeh S, Rahnama K, Nasrollahnejad S, Fotouhifar KB, Hemmati K, White JF, et al. Isolation and identification of L-asparaginase-producing endophytic fungi from the Asteraceae family plant species of Iran. PeerJ. 2020 Jan 14;8:e8309. ##Andrade KCR, Fernandes RA, Pinho DB, de Freitas MM, Filho EXF, Pessoa A, et al. Sequencing and characterization of an L-asparaginase gene from a new species of Penicillium section Citrina isolated from Cerrado. Sci Rep 2021 Sep 9;11(1):17861. ##Doriya K, Kumar DS. Isolation and screening of L-asparaginase free of glutaminase and urease from fungal sp. 3 Biotech. 2016 Dec;6(2):239. ##Sisay T, Mobegi VA, Wachira S, Maina N. Isolation and characterization of fungi producing L-asparaginase with reduced L-glutaminase activity from soil samples. Electronic Journal of Biotechnology 2024 Sep 1;71:10-8.##Beckett A, Gervais D. What makes a good new therapeutic L-asparaginase? World J Microbiol Biotechnol 2019 Sep 24;35(10):152. ##Baral A, Gorkhali R, Basnet A, Koirala S, Bhattarai HK. Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach. JMIRx Med 2021 Sep 8;2(3):e29844. ##Rigouin C, Nguyen HA, Schalk AM, Lavie A. (2017). Discovery of human-like L-asparaginases with potential clinical use by directed evolution. Scientific reports, 7(1), 10224.##Robinson PK. (2015). Enzymes: principles and biotechnological applications. Essays in biochemistry, 59, 1.##Daniel RM, Danson MJ. (2010). A new understanding of how temperature affects the catalytic activity of enzymes. Trends in biochemical sciences,35(10), 584-91.##Verma N, Kumar K, Kaur G, Anand S. (2007). L-asparaginase: a promising chemotherapeutic agent. Critical reviews in biotechnology, 27(1), 45-62##Imada A, Igarasi S, Nakahama K, Isono M. (1973). Asparaginase and glutaminase activities of micro-organisms. Microbiology, 76(1), 85-99.##Amena S, Vishalakshi N, Prabhakar M, Dayanand A, Lingappa K. Production, purification and characterization of l-asparaginase from streptomyces gulbargensis. Braz J Microbiol 2010 Jan;41(1):173-8. ##Manna S, Sinha A, Sadhukhan R, Chakrabarty SL. Purification, characterization and antitumor activity of L-asparaginase isolated from Pseudomonas stutzeri MB-405. Curr Microbiol 1995 May;30(5):291-8. ##Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 May 7;72:248-54. ##Machado KM, Matheus DR. Biodegradation of remazol brilliant blue R by ligninolytic enzymatic complex produced by Pleurotus ostreatus. Brazilian Journal of Microbiology 2006;37:468-73.##Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 Aug 15;227(5259):680-5. ##Shifrin S, Parrott CL, Luborsky SW. Substrate binding and intersubunit interactions in L-asparaginase. J Biol Chem 1974 Mar 10;249(5):1335-40. ##Lineweaver H, Burk D. The determination of enzyme dissociation constants. Journal of the American Chemical Society 1934 Mar;56(3):658-66.##Meghavarnam AK, Janakiraman S. Purification and characterization of therapeutic enzyme L-asparaginase from a tropical soil fungal isolate Fusarium culmorum ASP-87. J Anesth Crit Care Open Access 2015;2(5):00064.##Connolly JM, Rose DP. Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate 1989;15(2):177-86. ##Bahraminasab M, Arab S, Jahan A. Adaptation of MC3T3 cell line to Dulbecco&#39;s Modified Eagle&#39;s medium. Tissue Cell. 2020 Jun;64:101341. ##Aishwarya SS, Selvarajan E, Iyappan S, Rajnish KN. Recombinant l-Asparaginase II from Lactobacillus casei subsp. casei ATCC 393 and Its Anticancer Activity. Indian J Microbiol 2019 Sep;59(3):313-320. ##Kamiloglu S, Sari G, Ozdal T, Capanoglu E. Guidelines for cell viability assays. Food Frontiers 2020 Sep;1(3):332-49.##Muruthi CW, Ngugi MP, Runo SM, Mwitari PG. In Vitro Antiproliferative Effects and Phytochemical Characterization of Carissa edulis ((Forssk) Vahl) and Pappea capensis (Eckyl and Zeyh) Extracts. J Evid Based Integr Med 2023 Jan-Dec;28:2515690X231187711.##Arifin WN, Zahiruddin WM. Sample Size Calculation in Animal Studies Using Resource Equation Approach. Malays J Med Sci 2017 Oct;24(5):101-105.##Mohamed SA, Elshal MF, Kumosani TA, Aldahlawi AM, Basbrain TA, Alshehri FA, et al. L-Asparaginase Isolated from Phaseolus vulgaris Seeds Exhibited Potent Anti-Acute Lymphoblastic Leukemia Effects In-Vitro and Low Immunogenic Properties In-Vivo. Int J Environ Res Public Health 2016 Oct 14;13(10):1008. ##Rathod S, Ramsey M, Relling MV, Finkelman FD, Fernandez CA. Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII. Haematologica 2019 Feb;104(2):319-29.##Ratnayani K, Kusumaningrum NW. Isolation of Protease enzyme from chayote fruit (sechium edule (Jacq.) Sw.) with ammonium sulfate fractination method. International Journal of Biosciences and Biotechnology 2011;2:78-82.##Scott JE, Williams KP. Validating identity, mass purity and enzymatic purity of enzyme preparations. Assay Guidance Manual [Internet]. 2012 Oct 1.##Sharma H, Upadhyay SK. Enzymes and their production strategies. In: Biomass, biofuels, biochemicals 2020 Jan 1 (pp. 31-48). Elsevier.##Kozak M, Jurga S. A comparison between the crystal and solution structures of Escherichia coli asparaginase II. Acta Biochim Pol 2002;49(2):509-13. ##Huang L, Liu Y, Sun Y, Yan Q, Jiang Z. Biochemical characterization of a novel L-Asparaginase with low glutaminase activity from Rhizomucor miehei and its application in food safety and leukemia treatment. Appl Environ Microbiol 2014 Mar;80(5):1561-9. ##Nguyen HA, Su Y, Lavie A. Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity. J Biol Chem 2016 Aug 19;291(34):17664-76. ##Moubasher HA, Balbool BA, Helmy YA, Alsuhaibani AM, Atta AA, Sheir DH, et al. Insights into Asparaginase from Endophytic Fungus Lasiodiplodia theobromae: Purification, Characterization and Antileukemic Activity. Int J Environ Res Public Health 2022 Jan 7;19(2):680.##Borkotaky B, Bezbaruah RL. Production and properties of asparaginase from a new Erwinia sp. Folia Microbiol (Praha) 2002;47(5):473-6. ##Pedreschi F, Kaack K, Granby K. The effect of asparaginase on acrylamide formation in French fries. Food Chem 2008 Jul 15;109(2):386-92. ##El-Naggar NE, Deraz SF, Soliman HM, El-Deeb NM, El-Ewasy SM. Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82. Sci Rep 2016 Sep 8;6:32926.##Shrivastava A, Khan AA, Shrivastav A, Jain SK, Singhal PK. Kinetic studies of L-asparaginase from Penicillium digitatum. Prep Biochem Biotechnol 2012;42(6):574-81. ##Ho PP, Frank BH, Burck PJ. Crystalline L-asparaginase from escherichia coli B. Science. 1969 Aug 1;165(3892):510-2. ##Gervais D, Foote N. Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzyme. Mol Biotechnol 2014 Oct;56(10):865-77. ##Dumina M, Zhgun A, Pokrovskaya M, Aleksandrova S, Zhdanov D, Sokolov N, et al. A Novel L-Asparaginase from Hyperthermophilic Archaeon Thermococcus sibiricus: Heterologous Expression and Characterization for Biotechnology Application. Int J Mol Sci 2021 Sep 13;22(18):9894. ##Sobat M, Asad S, Kabiri M, Mehrshad M. Metagenomic discovery and functional validation of L-asparaginases with anti-leukemic effect from the Caspian Sea. iScience 2021 Jan 5;24(1):101973.##Vala AK, Sachaniya B, Dudhagara D, Panseriya HZ, Gosai H, Rawal R, et al. Characterization of L-asparaginase from marine-derived Aspergillus niger AKV-MKBU, its antiproliferative activity and bench scale production using industrial waste. Int J Biol Macromol 2018 Mar;108:41-46. ##Luhana K, Bariya H. Comparative analysis of purified anti-leukemic L-asparaginase enzyme from Trichoderma spp. Journal of Applied Biology &amp; Biotechnology Vol 2023 Jul;11(4):185-92.##Ali D, Ouf S, Eweis M, Solieman D. Optimization of L-asparaginase production from some filamentous fungi with potential pharmaceutical properties. Egyptian Journal of Botany 2018 Dec 1;58(3):355-69.##El-Naggar NE, El-Shweihy NM. Bioprocess development for L-asparaginase production by Streptomyces rochei, purification and in-vitro efficacy against various human carcinoma cell lines. Sci Rep 2020 May 14;10(1):7942. ##Platts-Mills TA. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med 2001 Oct 15;164(8 Pt 2):S1-5.##Zachary JF, McGavin MD, editors. Pathologic Basis of Veterinary Disease5: Pathologic Basis of Veterinary Disease. Elsevier Health Sciences; 2012.##Saeed H, Hemida A, Abdel-Fattah M, Eldoksh A, Shalaby M, Nematalla H, et al. Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines. Protein Expr Purif 2021 May;181:105820. ##Nogami-Hara A, Shimada A, Mio M. Influence of cyclophosphamide on L-Asparaginase-induced allergy in animal model. Blood 2019 Nov 13;134:5119.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Synthesis of a Unique Dextran Polymer-Conjugated Antibody and Horseradish Peroxidase Complex</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Immunohistochemistry (IHC) is a practical technique that utilizes the specific binding between an antigen and antibody to detect and localize specific antigens in tissue and cells. The optimal sensitivity in IHC is of utmost importance to achieve reliable results even when antigens are present at low abundance on the samples. Here, a dextran polymer labeled with Horseradish Peroxidase (HRP) and an anti-body to improve the sensitivity of the IHC technique was synthesized. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; To this end, free thiol groups were introduced on sodium periodate-activated 30 &lt;em&gt;kDa&lt;/em&gt; dextran using cystamine, followed by attachment of sulfo-MBS-activated goat anti-mouse antibody and sulfo-MBS-activated HRP to the activated dextran. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The production of Poly-HRP Antibody (PHA) was confirmed by the appearance of a new protein band exceeding 150 &lt;em&gt;kDa&lt;/em&gt; on Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE). Additionally, Enzyme-Linked Immunosorbent Assay (ELISA) and IHC techniques were employed to characterize PHA&amp;rsquo;s functionality. The data demonstrated that PHA effectively detected target antigens in these assays. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The newly synthesized PHA has the potential to provide a more sensitive platform for early detection of biomarkers in IHC. Further research is needed to evaluate its cost-effectiveness. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>180</FPAGE>
            <TPAGE>185</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Bahareh</Name>
<MidName></MidName>
<Family>Zamani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR)</Organization>
</Organizations>
<Universities>
<University>Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR)</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Niloofar</Name>
<MidName></MidName>
<Family>Agharezaee</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR)</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Farshid</Name>
<MidName></MidName>
<Family>Moosavi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR)</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Saeideh</Name>
<MidName></MidName>
<Family>Zamani Koukhaloo</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR)</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Parisa</Name>
<MidName></MidName>
<Family>Yousefi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR)</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Jafar</Name>
<MidName></MidName>
<Family>Mahmoudian</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Antibodies</KeyText></KEYWORD><KEYWORD><KeyText>Dextrans</KeyText></KEYWORD><KEYWORD><KeyText>Horseradish peroxidase</KeyText></KEYWORD><KEYWORD><KeyText>Immunohistochemistry</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70617.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Su F, Luo X, Du Z, Chen Z, Liu Y, Jin X, Guo Z, Lu J, Jin D. High-contrast luminescent immunohistochemistry using PEGylated lanthanide complexes. Anal Chem 2022 Dec 5;94(50):17587-94.##Fanjul-Bolado P, Gonz&#225;lez-Garc&#237;a MB, Costa-Garc&#237;a A. Amperometric detection in TMB/HRP-based assays. Anal Bioanal Chem 2005;382(2):297-302.##von Ruhland CJ. Application of an optimized marker amplification protocol in immunohistochemistry—a valuable tool for visualizing antigenic sites of low signal strength or sparse distribution. Biotech Histochem 2018 Oct 3;93(7):478-84.##Rizk EM, Gartrell RD, Barker LW, Esancy CL, Finkel GG, Bordbar DD, et al. Prognostic and predictive immunohistochemistry-based biomarkers in cancer and immunotherapy. Hematol Oncol Clin North Am 2019;33(2):291-9. ##Sukswai N, Khoury JD. Immunohistochemistry innovations for diagnosis and tissue-based biomarker detection. Curr Hematol Malig Rep 2019;14(5):368-75. ##Niemeyer CM, editor. Bioconjugation protocols: strategies and methods. Springer Science &amp; Business Media; 2008 Feb 4.##Wong SS. Chemistry of protein conjugation and cross-linking. CRC press; 1991 Jun 18.##Hnasko RM. Bioconjugation of Antibodies to Horseradish Peroxidase (HRP). Methods Mol Biol 2015:43-50.##Boorsma D, Streefkerk J. Peroxidase-conjugate chromatography isolation of conjugates prepared with glutaraldehyde or periodate using polyacrylamide-agarose gel. J Histochem Cytochem 1976;24(3):481-6. ##Dhawan S. Signal amplification systems in immunoassays: implications for clinical diagnostics. Expert Rev Mol Diagn 2006;6(5):749-60.##Harlow E, Lane D. Using antibodies: a laboratory manual: CSHL Press; 1999.##Buchwalow IB, B&#246;cker W. Immunohistochemistry: basics and methods. Springer Science &amp; Business Media; 2010 Jan 26.##Shojaeian S, Lay NM, Zarnani AH. Detection systems in immunohistochemistry. InImmunohistochemistry-The Ageless Biotechnology 2018 Dec 17. London: IntechOpen.##Ivell R, Teerds K, Hoffman GE. Proper application of antibodies for immunohistochemical detection: antibody crimes and how to prevent them. Endocrinology 2014 Mar 1;155(3):676-87. ##Mason D, Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents.  J Clin Pathol 1978;31(5):454-60. ##Ramos-Vara J, Miller M. When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry—the red, brown, and blue technique. Vet Pathol 2014;51(1):42-87. ##Harley R, Gruffydd-Jones T, Day M. Non-specific labelling of mast cells in feline oral mucosa—A potential problem in immunohistochemical studies. J Comp Pathol 2002;127(2-3):228-31. ##Johnson DA, Gautsch JW, Sportsman JR, Elder JH. Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Analysis Techniques 1984 Jan 1;1(1):3-8.##Balieiro Neto G, Engracia Filho JR, Budino FE, Freitas AW, Soares WV. Effects of High-Biotin Sample Interference on Antibody Concentrations in Sandwich Immunoassays. Vaccines (Basel) 2023 Oct 24;11(11):1627. ##Duhamel RC, Johnson DDA. Use of nonfat dry milk to block nonspecific nuclear and membrane staining by avidin conjugates. J Histochem Cytochem 1985;33(7):711-4. ##Banerjee D, Pettit S. Endogenous avidin-binding activity in human lymphoid tissue. J Clin Pathol 1984;37(2):223-5.##Zarnani AH, Moazzeni SM, Shokri F, Salehnia M, Jeddi-Tehrani M. Kinetics of murine decidual dendritic cells. Reproduction 2007;133(1):275-83. ##Lakshmipriya T, Gopinath SC, Tang TH. Biotin-streptavidin competition mediates sensitive detection of biomolecules in enzyme linked immunosorbent assay. PLoS One 2016 Mar 8;11(3):e0151153. ##Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29(4):577-80.##Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, et al. The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998;51(7):506-11. ##Buchwalow I, Boecker W, Wolf E, Samoilova V, Tiemann M. Signal amplification in immunohistochemistry: loose-jointed deformable heteropolymeric HRP conjugates vs. linear polymer backbone HRP conjugates. Acta Histochemica 2013;115(6):587-94. ##Mahmoudian J, Nazari M, Ghods R, Jeddi-Tehrani M, Ostad SN, Ghahremani MH, et al. Expression of Human Placenta-specific 1 (PLAC1) in CHO-K1 Cells. Avicenna J Med Biotechnol 2020;12(1):24-31.##Ellman GL, Courtney KDA, Andres V, Jr., Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95. ##Kitagawa T, Aikawa T. Enzyme coupled immunoassay of insulin using a novel coupling reagent. J Biochem 1976;79(1):233-6. ##Charbgoo F, Mirshahi M, Sarikhani S, Saifi Abolhassan M. Synthesis of a unique high-performance poly-horseradish peroxidase complex to enhance sensitivity of immunodetection systems. Biotechnol Appl Biochem 2012;59(1):45-9. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>The Quality and Quantity of Nanoparticles Extracted from Human Adipose Tissue  Derived-Mesenchymal Stem Cells </TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Nanoparticles, as small extracellular vesicles, are considered promising tools in tissue engineering and regenerative medicine. This study aimed to investigate the effects of different processing and culture condition on &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;the quality and quantity of extracts derived from human Adipose-Mesenchymal Stem Cells (AD-MSCs).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;:&lt;/span&gt;&lt;/strong&gt; &lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;AD-MSCs&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; were proliferated in both the experimental and control groups. Nanoparticles were extracted from AD-MSCs-extracts and analyzed using &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;SEM, TEM, DLS, Zeta potential, FTIR and BCA analyses&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;The morphological characteristics (shape, size, distribution, surface topography, and&amp;nbsp;&lt;strong&gt; &lt;/strong&gt;agglomeration/aggregation&lt;strong&gt;), &lt;/strong&gt;structural&lt;strong&gt; &lt;/strong&gt;appearance (poly-disperse intensity, colloidal particle behavior, surface charge, and stability), chemical properties (functional groups and ionic interactions) and total protein concentration were detected in the extracted nanoparticles.&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;Additionally, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;the morphological characteristics, apoptosis, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;mitochondrial oxidoreductase activity, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;and migration potential of AD-MSCs in both groups were evaluated using acridine orange staining, MTT, and scratch assays. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;In the experimental group, 100% of the nanoparticles had a diameter of 112.8&amp;plusmn;25 &lt;em&gt;nm&lt;/em&gt;, with the most frequency of 111.4 &lt;em&gt;nm&lt;/em&gt;. However, in the control group, 72% of nanoparticles had a diameter of 350.2&amp;plusmn;43.6 &lt;em&gt;nm &lt;/em&gt;with the highest frequency of 339.8 &lt;em&gt;nm &lt;/em&gt;(&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;p&amp;le;0.05). &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;The Z-average, Poly-disperse intensity, and &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;electrostatic stability&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; of nanoparticles in the control and experimental groups were 171.9 &lt;em&gt;nm&lt;/em&gt;, 0.727 and &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-0.000011 &lt;em&gt;cm&lt;sup&gt;2&lt;/sup&gt;/Vs&lt;/em&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; &lt;em&gt;vs.&lt;/em&gt; 103.7 &lt;em&gt;nm&lt;/em&gt;, 0.205 and &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;0.000481 &lt;em&gt;cm&lt;sup&gt;2&lt;/sup&gt;/Vs,&lt;/em&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; respectively (&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;p&amp;le;0.05). &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;In the experimental group, Zeta potential was -61.8 &lt;em&gt;mV&lt;/em&gt;, which is in the range of &amp;zeta; &amp;gt;-30&lt;em&gt;mV&lt;/em&gt;. Although, Zeta potential in the control group was -1.5 &lt;em&gt;mV&lt;/em&gt;, which is in the range of -30 &lt;em&gt;mV &lt;/em&gt;&amp;lt;&amp;zeta; &amp;lt;30 &lt;em&gt;mV&lt;/em&gt; (&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;p&amp;le;0.05&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;).&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;Total protein concentrations in the control and experimental groups were &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;11 and 41%, respectively (p&amp;le;0.05).&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Nanoparticles derived from AD-MSCs have high therapeutic applications in tissue engineering and regenerative medicine. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>186</FPAGE>
            <TPAGE>195</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mobina</Name>
<MidName></MidName>
<Family>Karimi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, SR.C, Islamic Azad University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, SR.C, Islamic Azad University</University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Banafsheh</Name>
<MidName></MidName>
<Family>Heidari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Hanieh</Name>
<MidName></MidName>
<Family>Jafary </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, SR.C, Islamic Azad University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, SR.C, Islamic Azad University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Kavosh</Name>
<MidName></MidName>
<Family>Zandsalimi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Medical Laser (MLRC), Medical Laser Research Center, Yara Institute, ACECR</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Acridine orange</KeyText></KEYWORD><KEYWORD><KeyText>Control groups</KeyText></KEYWORD><KEYWORD><KeyText>Fourier transform infrared</KeyText></KEYWORD><KEYWORD><KeyText>Immunologic factors</KeyText></KEYWORD><KEYWORD><KeyText>Nanoparticles</KeyText></KEYWORD><KEYWORD><KeyText>Obesity</KeyText></KEYWORD><KEYWORD><KeyText>Regenerative medicine</KeyText></KEYWORD><KEYWORD><KeyText>Regenerative medicine</KeyText></KEYWORD><KEYWORD><KeyText>Spectroscopy</KeyText></KEYWORD><KEYWORD><KeyText>Static electricity</KeyText></KEYWORD><KEYWORD><KeyText>Tissue engineering </KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70618.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Cai Y, Li J, Jia C, He Y, Deng, C. Therapeutic applications of adipose cell-free derivatives: a review. Stem Cell Res Ther 2020;11(1):312. ##Barreca MM, Cancemi P, Geraci F. Mesenchymal and induced pluripotent stem cells-derived extracellular vesicles: the new frontier for regenerative medicine? Cells 2020;9(5):1163. ##Chen B, Li Q, Zhao B, Wang Y. Stem cell-derived extracellular vesicles as a novel potential therapeutic tool for tissue repair. Stem Cells Transl Med 2017;6(9):1753-8. ##Baglio SR, Rooijers K, Koppers-Lalic D, Verweij FJ, P&#233;rez Lanz&#243;n M, Zini N, et al. Human bone marrow-and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther 2015;6(1):127. ##Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science 2020;367(6478):eaau6977. ##Kiyota T, Machhi J, Lu Y, Dyavarshetty B, Nemati M, Yokoyama I, et al. Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer’s disease mice. J Neuroimmunol 2018;319:80-92. ##Dittmer J, Leyh B. Paracrine effects of stem cells in wound healing and cancer progression. Int J Oncol 2017;44(6):1789-98. ##Gao Y, Yuan Z, Yuan X, Wan Z, Yu Y, Zhan Q, et al. Bioinspired porous microspheres for sustained hypoxic exosomes release and vascularized bone regeneration. Bioact Mater 2022;14:377-88.##Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 2019;8(4):307. ##Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 2015;373(24):2336-46. ##Nam G-H, Choi Y, Kim GB, Kim S, Kim SA, Kim I-S. Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv Mater 2020;32(51):2002440. ##Vu NB, Nguyen HT, Palumbo R, Pellicano R, Fagoonee S, Pham PV. Stem cell-derived exosomes for wound healing: current status and promising directions. Minerva Med 2021;112(3):384-400. ##Zhang Y, Jiayao B, Huang J, Tang Y, Du Sh, Pengyue L. Exosome: A review of its classification, isolation, storage, diagnostic and targeted therapy applications. Int J Nanomedicine 2020;15:6917-34. ##Heidari B, Jaffary H, Golshahi H, Soltanghoraei H, Shams S, Soltani A, et al. Efficient procedure for human adipose tissue cryopreservation without specialized freezing equipment. Cryoletters 2025;46(3):197-206. ##Heidari B, Eidi N, Mortazavi P, Saffarian Z, Soltani A, Mansouri P, et al. Morphological characteristics, mitochondrial oxidoreductase activity, and vascularization of human adipose tissues pre-and post-xenotransplantation into BALB/c female nude mice. Cryobiology 2025; 2025 May 6;119:105248. ##Safwani WKZW, Wong CW, Yong KW, Choi JR, Adenan NAM, Omar S, et al. The effects of hypoxia and serum-free conditions on the stemness properties of human adipose-derived stem cells. Cytotechnology 2016;68(5):1859. ##Kim JY, Rhim WK, Seo HJ, Lee JY, Park CG, Han DK. Comparative analysis of MSC-derived exosomes depending on cell culture media for regenerative bioactivity. Tissue Eng Regen Med 2021;18(3):355-67. ##Wei Q, Wei L, Zhang J, Li Z, Feng H, Ren L. EphA2 enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer. Mol Med Rep 2020;22(4):2941-7. ##Misaghian A, Ghadiri AA, Asadirad A, Amirzadeh S, Amari A. The Effect of Exosomes Isolated from Poly (I:C) Treated Human Wharton&#39;s Jelly Mesenchymal Stem Cells on CD4+CD25+Foxp3+ Regulatory T Cells. Iran J Allergy Asthma Immunol 2024;23(3):288-98. ##Dong B, Wang C, Zhang J, Zhang J, Gu Y, Guo X, Zuo X, Pan H, Hsu ACY, Wang G, Wang F.  Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization. Stem Cell Res Ther 2021;12(1):204. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Resorbable Bone-Fixation Materials: Synthesis, Physical-Chemical and Biological  Properties</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;Artificial bone materials were synthesized using the &amp;quot;solvent casting method&amp;quot; using polylactide/hydroxyapatite and various organic-inorganic modifiers.&lt;/span&gt; &lt;span style=&quot;font-size:11.0pt&quot;&gt;The physicochemical properties of the materials were studied using modern methods. IR spectroscopy showed that interactions between polymer macromolecules and hydroxyapatite occurred.&lt;/span&gt; &lt;span style=&quot;font-size:11.0pt&quot;&gt;When the powder was studied by the X-ray diffraction method, it was found to have an average crystallinity of 50-60%.&lt;/span&gt; &lt;span style=&quot;font-size:11.0pt&quot;&gt;When the textural properties were examined using SEM analysis, it was found that the introduction of magnesium phosphate into the samples resulted in the formation of porous particles with dimensions of 100-250 &lt;em&gt;&amp;micro;m&lt;/em&gt;. This in turn, leads to the improvement of metabolic processes when the samples are introduced into living tissues.&lt;/span&gt; &lt;span style=&quot;font-size:11.0pt&quot;&gt;When the microhardness was determined by the Vickers method, it was found to be close to the hardness of natural bone, &lt;em&gt;i.e.&lt;/em&gt; 27-34 HV.&lt;/span&gt; &lt;em&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;In vitro&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt; resorption was also performed in &lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;S&lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;imulated &lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;B&lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;ody &lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;F&lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;luids (SBF). Non-toxicity was observed when cytotoxic properties were studied.&lt;/span&gt; &lt;span style=&quot;font-size:11.0pt&quot;&gt;When the resorption process was studied &lt;em&gt;in vivo&lt;/em&gt; in the upper third of the femur of rabbits, it was found that the ossification process of the samples was satisfactory after 28 days&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>196</FPAGE>
            <TPAGE>207</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Bakhtiniso</Name>
<MidName></MidName>
<Family>Muzaffarova</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Organic synthesis and Bioorganic chemistry, Samarkand State University named after Sharof Rashidov</Organization>
</Organizations>
<Universities>
<University>Department of Organic synthesis and Bioorganic chemistry, Samarkand State University named after Sharof Rashidov</University>
</Universities>
<Countries>
<Country>Uzbekistan</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sherzod</Name>
<MidName></MidName>
<Family>Eranov</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Traumatology and Orthopedics, Samarkand State Medical University</Organization>
</Organizations>
<Universities>
<University>Department of Traumatology and Orthopedics, Samarkand State Medical University</University>
</Universities>
<Countries>
<Country>Uzbekistan</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sanjar</Name>
<MidName></MidName>
<Family>Tillayev</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Durapatite</KeyText></KEYWORD><KEYWORD><KeyText>Femur</KeyText></KEYWORD><KEYWORD><KeyText>Hydroxyapatite-polylactide</KeyText></KEYWORD><KEYWORD><KeyText>Lagomorpha</KeyText></KEYWORD><KEYWORD><KeyText>Porosity</KeyText></KEYWORD><KEYWORD><KeyText>Powders</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70619.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Campana V, Milano G, Pagano E, Barba M, Cicione C, Salonna G, et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med 2014 Oct;25(10):2445-61. ##Chai Y, Okuda M, Otsuka Y, Ohnuma K, Tagaya M. Comparison of two fabrication processes for biomimetic collagen/hydroxyapatite hybrids. Advanced Powder Technology 2019 Jul 1;30(7):1419-23.##Irawan V, Kajiwara D, Nakagawa Y, Ikoma T. Fabrication of mechanically robust bilayer membranes of hydroxyapatite/collagen composites. Materials Letters 2021 May 15;291:129514.##&#199;elik T, Sara&#231;oğlu B, &#214;zkan A, İlhan Y. Biodegradable Pla/Ha Composite Material Production and Mechanical Characterization for Temporary Implant Applications. International Journal of Pioneering Technology and Engineering 2023 Dec 15;2(02):188-92.##Aihemaiti P, Jiang H, Aiyiti W, Wang J, Dong L, Shuai C. Mechanical properties enhancement of 3D-printed HA-PLA composites using ultrasonic vibration assistance. Virtual and Physical Prototyping 2024 Dec 31;19(1):e2346271.##Li M, Jia W, Zhang X, Weng H, Gu G, Chen Z. Hyaluronic acid oligosaccharides modified mineralized collagen and chitosan with enhanced osteoinductive properties for bone tissue engineering. Carbohydr Polym 2021 May 15;260:117780. ##Luo W, Cheng L, Yuan C, Wu Z, Yuan G, Hou M, et al. Preparation, characterization and evaluation of cellulose nanocrystal/poly(lactic acid) in situ nanocomposite scaffolds for tissue engineering. Int J Biol Macromol 2019 Aug 1;134:469-479. ##Nukavarapu SP, Kumbar SG, Brown JL, Krogman NR, Weikel AL, Hindenlang MD, et al. Polyphosphazene/nano-hydroxyapatite composite microsphere scaffolds for bone tissue engineering. Biomacromolecules 2008 Jul;9(7):1818-25. ##ShiraliPour F, Shafiei SS, Nikakhtar Y. Three‐dimensional porous poly (ε‐caprolactone)/beta‐tricalcium phosphate microsphere‐aggregated scaffold for bone tissue engineering. International Journal of Applied Ceramic Technology 2021 Sep;18(5):1442-56.##Khosalim IP, Zhang YY, Yiu CKY, Wong HM. Synthesis of a graphene oxide/agarose/hydroxyapatite biomaterial with the evaluation of antibacterial activity and initial cell attachment. Sci Rep 2022 Feb 4;12(1):1971. ##Zhang Y, Wang W, Chen Z, Shi H, Zhang W, Zhang X, et al. An artificial bone filling material of poly l-lactic acid/collagen/nano-hydroxyapatite microspheres: Preparation and collagen regulation on the property. Int J Biol Macromol 2023 Feb 28;229:35-50. ##Soloveva Vera Aleksandrovna. Composites on the basis of biodecomposed polymers for implantatov in maxillofacial surgery: Dissertation. Chem.Sci. 05.17.06 Moscow, 2005 150 p. ##Boruvka M, Cermak C, Behalek L, Brdlik P. Effect of in-mold annealing on the properties of asymmetric poly (L-lactide)/poly (D-lactide) blends incorporated with nanohydroxyapatite. Polymers 2021 Aug 23;13(16):2835.##Targonska S, Dobrzynska-Mizera M, Wujczyk M, Rewak-Soroczynska J, Knitter M, Dopierala K, et al. New way to obtain the poly (L-lactide-co-D, L-lactide) blend filled with nanohydroxyapatite as biomaterial for 3D-printed bone-reconstruction implants. European Polymer Journal 2022 Feb 15;165:110997.##Vasenina IV, Savkin KP, Laput OA, Lytkina DN, Botvin VV, Medovnik AV, et al. Effects of ion-and electron-beam treatment on surface physicochemical properties of polytetrafluoroethylene. Surface and Coatings Technology 2018 Jan 25;334:134-41.##Parker NG, Mather ML, Morgan SP, Povey MJ. Longitudinal acoustic properties of poly(lactic acid) and poly(lactic-co-glycolic acid). Biomed Mater 2010 Oct;5(5):055004. ##Cai N, Dai Q, Wang Z, Luo X, Xue Y, Yu F. Preparation and properties of nanodiamond/poly (lactic acid) composite nanofiber scaffolds. Fibers and Polymers 2014 Dec;15:2544-52.##Teamsinsungvon A, Ruksakulpiwat Y, Jarukumjorn K. Poly (lactic acid)/Poly (butylene adipate-co-terephthalate) Blend and its Composite: Effect of Maleic Anhydride Grafted Poly (lactic acid) as a Compatibilizer. Advanced Materials Research. 2012 Feb 15;410:51-4.##Vu MC, Jeong TH, Kim JB, Choi WK, Kim DH, Kim SR. 3D printing of copper particles and poly (methyl methacrylate) beads containing poly (lactic acid) composites for enhancing thermomechanical properties. Journal of Applied Polymer Science 2021 Feb 5;138(5):49776.##Maeda H, Kasuga T, Nogami M. Bonelike apatite coating on skeleton of poly (lactic acid) composite sponge. Materials Transactions 2004;45(4):989-93.##Pandele AM, Constantinescu A, Radu IC, Miculescu F, Ioan Voicu S, et al. Synthesis and Characterization of PLA-Micro-structured Hydroxyapatite Composite Films. Materials (Basel) 2020 Jan 8;13(2):274. ##Albano C, Gonz&#225;lez G, Palacios J, Karam A, Castillo RV, Covis M. Characterization of poly l-lactide/hydroxyapatite composite: Chemical, thermal and thermomechanical properties. Revista de la Facultad de Ingenier&#237;a Universidad Central de Venezuela 2013 Sep;28(3):97-107.##Zare RN, Doustkhah E, Assadi MH. Three-dimensional bone printing using hydroxyapatite-PLA composite. Materials Today: Proceedings 2021 Jan 1;42:1531-3.##Mohammadi-Zerankeshi M, Alizadeh R. 3D-printed PLA-Gr-Mg composite scaffolds for bone tissue engineering applications. Journal of Materials Research and Technology##Sun S, Gao L, Liang B, Yin Z, Pan S, Shi C, et al. Long-term and uniform release of magnesium ions from PLA porous composite materials oriently reinforced by Mg wires for potential bone repair application. Surfaces and Interfaces 2023 Aug 1;40:103018.##Jodeh S, Azzaoui K, Mejdoubi E, Lamhamdi A, Hammouti B, Akartasse N, Abidi N. Novel tricomponenets composites films from polylactic acid/hydroxyapatite/poly-caprolactone suitable for biomedical applications. J. Mater. Environ. Sci. 2016;7:761-9.##Nahm NJ, Conway JD. Resorbable polylactide membrane for the treatment of segmental bone defects. Injury 2022 Feb;53(2):376-80. ##Channasanon S, Kaewkong P, Tanodekaew S. Dual-Curing Polylactide for Resorbable Bone Cement. Key Engineering Materials 2019 May 10;798:77-82.##Thirumaran A, Doulgkeroglou MN, Sankar M, Easley JT, Gadomski B, Poudel A, et al. A functional analysis of a resorbable citrate-based composite tendon anchor. Bioact Mater 2024 Jul 22;41:207-20. ##Pierre Lascombes, Pierre Journeau, Dmitry A. Popkov. Resorbable implants in paediatric orthopaedics and traumatology. Genij Ortopedii 2023;29(6):629-34.##Harper LT, Ahmed I, Felfel RM, Qian C. Finite element modelling of the flexural performance of resorbable phosphate glass fibre reinforced PLA composite bone plates. J Mech Behav Biomed Mater 2012 Nov;15:13-23. ##Guo W, Bu W, Mao Y, Wang E, Yang Y, Liu C, et al. Magnesium Hydroxide as a Versatile Nanofiller for 3D-Printed PLA Bone Scaffolds. Polymers (Basel) 2024 Jan 9;16(2):198. ##Serim TM, Amasya G, Eren-B&#246;nc&#252; T, Şengel-T&#252;rk CT, &#214;zdemir AN. Electrospun nanofibers: building blocks for the repair of bone tissue. Beilstein J Nanotechnol 2024 Jul 25;15:941-53. ##Hwang HS, Lee CS. Nanoclay-Composite Hydrogels for Bone Tissue Engineering. Gels 2024 Aug 3;10(8):513. ##Erol I, Mutlu T, Hazman &#214;, Khamidov G. Effect of a new methacrylate polymer with chlorobenzyl amide side group and biosynthesized ZnO nanoparticles on thermal and biological properties of chitosan. Cellulose 2024 Sep;31(14):8587-608.##Gligorijević BR, Vilotijević MN. Simulated body fluids prepared with natural buffers and system for active pH regulation. Iranian Journal of Chemistry and Chemical Engineering 2022;41(9):2918-35.##Luo W, Cheng L, Yuan C, Wu Z, Yuan G, Hou M, et al. Preparation, characterization and evaluation of cellulose nanocrystal/poly(lactic acid) in situ nanocomposite scaffolds for tissue engineering. Int J Biol Macromol 2019 Aug 1;134:469-79. ##Wee CY, Yang Z, Thian ES. Past, present and future development of microspheres for bone tissue regeneration: a review. Materials Technology 2021 May 12;36(6):364-74.##Sivrier M, Hazman &#214;, Tillayev S, Erol I. Novel bionanocomposites containing green synthesized silver NPs of a carboxymethyl cellulose-based blend; thermal, optical, biological and dielectric properties. Journal of Polymers and the Environment 2023 Sep;31(9):3857-74.##Hazman &#214;, Khamidov G, Yilmaz MA, Bozkurt MF, Kargioğlu M, Tukhtaev D, et al. Environmentally friendly silver nanoparticles synthesized from Verbascum nudatum var. extract and evaluation of its versatile biological properties and dye degradation activity. Environ Sci Pollut Res Int 2024 May;31(23):33482-94.  ##Guidelines for research ethics in science and technology//National Committee for Research Ethics in Science and Technology, Norway, Oslo, 3rd Edition, 2024. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Short-Term Inflammatory Exposure Affects Umbilical Cord-derived Mesenchymal Stem Cells Migration and Differentiation Through Modulation of NLRP3 Inflammasome Expression </TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; An innovative approach for tissue restoration using Umbilical Cord-derived Mesenchymal Stem Cells (UC-MSCs) is hindered by their poor survival rate due to the detrimental effects of the injured tissue microenvironment. Activation of NLRP3 inflammasome in an inflammatory environment which is followed by cellular impairment, has been reported. However, the expression of NLRP3 inflammasome in UC-MSCs in response to the inflammatory environment is not well understood. This study aims to investigate the impact of short-term exposure to an inflammatory environment induced by Lipopolysaccharide (LPS) on hUC-MSCs, focusing on cell viability, migration, differentiation, and the expression of NLRP3 inflammasome-related genes. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; hUC-MSC were exposed to LPS at concentration of 10 and 50 &lt;em&gt;&amp;mu;g/ml&lt;/em&gt; for 3 and 6 &lt;em&gt;hr&lt;/em&gt;. Cell viability was assessed using CCK-8 assay, migration capacity was evaluated using a scratch test, and differentiation capacity and the expression of NLRP3 inflammasome-related genes were measured using qRT-PCR.&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Short-term LPS induction did not affect the viability of hUC-MSCs but reduced their migration and differentiation capacity, particularly at 50 &lt;em&gt;&amp;mu;g/ml&lt;/em&gt; for both time points (p&amp;lt;0.05). The induction caused an increase in the mRNA levels of NLRP3, TLR-4, and RelA/p65, which correlated with elevated expression of caspase-1 and IL-1&amp;beta;.&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Short-term exposure to LPS influences hUC-MSCs by upregulating NLRP3, TLR4/ReIA (p65), IL-1&amp;beta;, and caspase-1 mRNA levels, leading to impaired migration and differentiation ability. This study underscores the significant impact of short-term exposure to an inflammatory microenvironment on hUC-MSC, potentially compromising their migration and differentiation capacity through the NLRP3 pathway. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>208</FPAGE>
            <TPAGE>215</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Helsy</Name>
<MidName></MidName>
<Family>Junaidi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Medicine, Universitas Indonesia</Organization>
</Organizations>
<Universities>
<University>Faculty of Medicine, Universitas Indonesia</University>
</Universities>
<Countries>
<Country>Indonesia </Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Dewi</Name>
<MidName></MidName>
<Family>Sukmawati </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Medicine, Universitas Indonesia</Organization>
</Organizations>
<Universities>
<University>Faculty of Medicine, Universitas Indonesia</University>
</Universities>
<Countries>
<Country>Indonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Anoop</Name>
<MidName></MidName>
<Family>Narayanan V </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangaluru</Organization>
</Organizations>
<Universities>
<University>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangaluru</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Jeanne</Name>
<MidName></MidName>
<Family>A. Pawitan </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Medicine, Universitas IndonesiaDepartment of Histology, Faculty of Medicine, Universitas IndonesiaStem Cell and Tissue Engineering (SCTE) Research Cluster, Indonesian Medical Education and Research Institute     (IMERI), Faculty of Medicine, Universitas IndonesiaIntegrated Service Unit of Stem Cell Medical Technology (IPT TK Sel Punca), Dr. Cipto Mangunkusumo General Hospital (RSCM)</Organization>
</Organizations>
<Universities>
<University>Faculty of Medicine, Universitas IndonesiaDepartment of Histology, Faculty of Medicine, Universitas IndonesiaStem Cell and Tissue Engineering (SCTE) Research Cluster, Indonesian Medical Education and Research Institute     (IMERI), Faculty of Medicine, Universitas IndonesiaIntegrated Service Unit of Stem Cell Medical Technology (IPT TK Sel Punca), Dr. Cipto Mangunkusumo General Hospital (RSCM)</University>
</Universities>
<Countries>
<Country>IndonesiaIndonesiaIndonesiaIndonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sri Widia</Name>
<MidName></MidName>
<Family>Jusman </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia</Organization>
</Organizations>
<Universities>
<University>Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia</University>
</Universities>
<Countries>
<Country>Indonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Inflammation</KeyText></KEYWORD><KEYWORD><KeyText>UC-MSC</KeyText></KEYWORD><KEYWORD><KeyText>Cell migration</KeyText></KEYWORD><KEYWORD><KeyText>Differentiation</KeyText></KEYWORD><KEYWORD><KeyText>Lipopolysaccharide</KeyText></KEYWORD><KEYWORD><KeyText>NLRP3 inflammasome</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70620.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Song N, Scholtemeijer M, Shah K. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends Pharmacol Sci 2020 Sep;41(9):653-64. ##Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol 2020 Sep;10(9):200223. ##Li L, Chen X, Wang WE, Zeng C. How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart? Stem Cells Int 2016;2016:9682757.##Ennis WJ, Sui A, Bartholomew A. Stem Cells and Healing: Impact on Inflammation. Adv Wound Care (New Rochelle) 2013 Sep;2(7):369-78.##Kurte M, Vega-Letter AM, Luz-Crawford P, Djouad F, Noel D, Khoury M, et al. Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation, leading to the opposite therapeutic outcome in EAE. Stem Cell Res Ther 2020 Sep;11(1):416.##Liu X, Yin S, Chen Y, Wu Y, Zheng W, Dong H, et al. LPS‑induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF‑kappaB, STAT3, or AP‑1 activation. Mol Med Rep 2018 April;17(4):5484-91.##Wan PX, Wang BW, Wang ZC. Importance of the stem cell microenvironment for ophthalmological cell-based therapy. World J Stem Cells 2015 Mar;7(2):448-60.##Leemans Jaklien C CSL, Sutterwala Fayyaz S. Sensing Damage by the NLRP3 inflammasome. Immunol Rev 2011 Sep 1;243(1):152-62.##Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis 2019;10(2):128.##Ahn JS, Seo Y, Oh SJ, Yang JW, Shin YY, Lee BC, et al. The activation of NLRP3 inflammasome potentiates the immunomodulatory abilities of mesenchymal stem cells in a murine colitis model. BMB Rep 2020 Jun;53(6):329-34. ##Oh JY, Ko JH, Lee HJ, Yu JM, Choi H, Kim MK, et al. Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species. Stem Cells 2014 Jun;32(6):1553-63. ##Hwang S, Sung DK, Kim YE, Yang M, Ahn SY, Sung SI, et al. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles. Int J Mol Sci 2023 Nov;24(22).16264-76.##Mani A, Hotra JW, Blackwell SC, Goetzl L, Refuerzo JS. Mesenchymal Stem Cells Attenuate Lipopolysaccharide-Induced Inflammatory Response in Human Uterine Smooth Muscle Cells. AJP Rep 2020 Jul;10(3):e335-e341.##Nunes PR, Peracoli MTS, Romao-Veiga M, Matias ML, Ribeiro VR, Da Costa Fernandes CJ, et al. Hydrogen peroxide-mediated oxidative stress induces inflammasome activation in term human placental explants. Pregnancy Hypertens 2018 Oct;14:29-36.##Shi H, Guo Y, Liu Y, Shi B, Guo X, Jin L, et al. The in vitro effect of lipopolysaccharide on proliferation, inflammatory factors, and antioxidant enzyme activity in bovine mammary epithelial cells. Anim Nutr 2016 Jun;2(2):99-104.##Yuan Y, Leiby KL, Greaney AM, Raredon MSB, Qian H, Schupp JC, et al. A Pulmonary Vascular Model From Endothelialized Whole Organ Scaffolds. Front Bioeng Biotechnol 2021Nov;9:760309. ##Kuntjoro M, Prasetyo EP, Cahyani F, Kamadjaja MJK, Hendrijantini N, Laksono H, et al. Lipopolysaccharide’s Cytotoxicity on Human Umbilical Cord Mesenchymal Stem Cells. Pesqui Bras Odontopediatria Clin Integr 2020 Aug;20:e0048. ##Hou YS, Liu LY, Chai JK, Yu YH, Duan HJ, Hu Q, et al. Lipopolysaccharide pretreatment inhibits LPS-induced human umbilical cord mesenchymal stem cell apoptosis via upregulating the expression of cellular FLICE-inhibitory protein. Mol Med Rep 2015 Aug;12(2):2521-8.##Li X-J, Huang F-Z, Wan Y, Li Y-S, Zhang WK, Xi Y, et al. Lipopolysaccharide Stimulated the Migration of NIH3T3 Cells Through a Positive Feedback Between β-Catenin and COX-2. Front Pharmacol 2018 Dec;19:9:1487. ##Zheng X, Zhang W, Hu X. Different concentrations of lipopolysaccharide regulate barrier function through the PI3K/Akt signaling pathway in human pulmonary microvascular endothelial cells. Sci Rep 2018 Jul 2;8(1):9963.##Antonei B. Csoka RM. LPS Treatment Alters Oligodendrocyte Precursor Cell Migration. The FASEB Journal 2020 Apr;34(S1):1. ##Page MJ, Kell DB, Pretorius E. The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation. Chronic Stress (Thousand Oaks) 2022 Jan-Dec; 6:24705470221076390.##Sen A, Ta M. Altered Adhesion and Migration of Human Mesenchymal Stromal Cells under Febrile Temperature Stress Involves NF-kappabeta Pathway. Sci Rep 2020 Mar 11;10(1):4473.##Sangaran PG, Ibrahim ZA, Chik Z, Mohamed Z, Ahmadiani A. Lipopolysaccharide Pre-conditioning Attenuates Pro-inflammatory Responses and Promotes Cytoprotective Effect in Differentiated PC12 Cell Lines via Pre-activation of Toll-Like Receptor-4 Signaling Pathway Leading to the Inhibition of Caspase-3/Nuclear Factor-kappaappa B Pathway. Front Cell Neurosci 2021 Jan;14:598453. ##Schmidt S, Friedl P. Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms. Cell Tissue Res 2010 Jan;339(1):83-92. ##Delarosa O, Dalemans W, Lombardo E. Toll-like receptors as modulators of mesenchymal stem cells. Front Immunol 2012 Jul 2;3:182.##Kaltschmidt C, Greiner JFW, Kaltschmidt B. The Transcription Factor NF-kappaB in Stem Cells and Development. Cells 2021 Aug;10(8):2042.##Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 2021 Feb;78(4):1233-61.##Li H, Sun L, Wang Y. Inhibition of LPS‑induced NLRP3 inflammasome activation by stem cell‑conditioned culture media in human gingival epithelial cells. Mol Med Rep 2023 May;27(5).106.##Honda TSB, Ku J, Anders H-J. Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis. Front Immunol 2023 Jul 25:14:1214289. ##Sun X, Hao H, Han Q, Song X, Liu J, Dong L, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther 2017;8(1):241.##Lou S, Duan Y, Nie H, Cui X, Du J, Yao Y. Mesenchymal stem cells: Biological characteristics and application in disease therapy. Biochimie 2021 Jun;185:9-21.##Fan M, Tong P, Yan L, Li T, Ren J, Huang J, et al. Detrimental alteration of mesenchymal stem cells by an articular inflammatory microenvironment results in deterioration of osteoarthritis. BMC Med 2023 Jun 19;21(1):215. ##Xiao J, Gong X, Fu Z, Song X, Ma Q, Miao J, et al. The influence of inflammation on the characteristics of adipose-derived mesenchymal stem cells (ADMSCs) and tissue repair capability in a hepatic injury mouse model. Stem Cell Res Ther 2023 Nov 19;14(1):334.##Chu Q, Jiang X, Xiao Y. Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease. Front Bioeng Biotechnol 2024 Sep 20;12:1468833.##Chen B, Chen Z, He M, Zhang L, Yang L, Wei L. Recent advances in the role of mesenchymal stem cells as modulators in autoinflammatory diseases. Front Immunol 2024 Dec 20;15:1525380. ##Planat-Benard V, Varin A, Casteilla L. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism. Front Immunol 2021 Apr 30;12:626755.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Ameliorating Potential of Quercetin and Curcumin on Glucose-6-Phosphate  Dehydrogenase Expression via miRNAs in Rats with Type 2 Diabetes Mellitus</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Type 2 diabetes mellitus (T2DM) is accompanied by a significant risk of oxidative stress. While a link between T2DM and G6PD deficiency has been suggested, their interaction is not precisely understood. Furthermore,&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; emerging evidence suggests an expression association between &lt;em&gt;G6PD&lt;/em&gt; and &lt;em&gt;miR-1, miR-122,&lt;/em&gt; and &lt;em&gt;miR-206&lt;/em&gt;. Given the antioxidant and anti-inflammatory properties of Curcumin (Cur) and Quercetin (Q), &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;This study aimed to assess the effects of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;curcumin and quercetin &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;on G6PD expression and its correlation with the mentioned microRNA expression in liver, renal, heart, and muscle in rats with T2DM.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; RT-qPCR was employed to determine &lt;em&gt;miR-1&lt;/em&gt;, &lt;em&gt;miR-122&lt;/em&gt;, &lt;em&gt;miR-206&lt;/em&gt;, and &lt;em&gt;G6PD&lt;/em&gt; expression. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The findings revealed that curcumin and quercetin treatment elevated &lt;em&gt;G6PD&lt;/em&gt; gene expression. Also, the treated groups exhibited down-regulation of &lt;em&gt;miR-1&lt;/em&gt;, &lt;em&gt;miR-122&lt;/em&gt;, and &lt;em&gt;miR-206&lt;/em&gt; (p&amp;lt;0.05). Furthermore, there was a significant inverse correlation between &lt;em&gt;G6PD&lt;/em&gt; and &lt;em&gt;miR-1&lt;/em&gt; in heart, &lt;em&gt;miR-122&lt;/em&gt; in all tissues except renal and &lt;em&gt;miR-206&lt;/em&gt; expression in skeletal muscle and heart (p&amp;lt;0.05).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; This study suggests that curcumin and quercetin may prevent the development of T2DM by effectively increasing &lt;em&gt;G6PD&lt;/em&gt; expression and reducing &lt;em&gt;miR-1&lt;/em&gt;, &lt;em&gt;miR-122&lt;/em&gt;, and &lt;em&gt;miR-206&lt;/em&gt; expression.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>216</FPAGE>
            <TPAGE>224</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mahsima</Name>
<MidName></MidName>
<Family>Bagheri</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>International Campus of Shahid Sadoughi University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>International Campus of Shahid Sadoughi University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ameneh</Name>
<MidName></MidName>
<Family>Khodarahmi </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services</Organization>
</Organizations>
<Universities>
<University>Department of Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName></MidName>
<Family>Zare Mehrjardi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ali</Name>
<MidName></MidName>
<Family>Moradi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Curcumin</KeyText></KEYWORD><KEYWORD><KeyText>G6PD</KeyText></KEYWORD><KEYWORD><KeyText>miRNA</KeyText></KEYWORD><KEYWORD><KeyText>Quercetin</KeyText></KEYWORD><KEYWORD><KeyText>Type 2 diabetes mellitus</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70621.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Krentz NAJ, Gloyn AL. Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics. Nat Rev Endocrinol 2020;16(4):202-12.##Engwa GA, Nwalo FN, Chibuzor GE, Ejiagha EC, Abonyi MC, Ugwu TE, et al. Relationship between type 2 diabetes and glucose-6 phosphate dehydrogenase (G6PD) deficiency and their effect on oxidative stress. Journal of Diabetes and Metabolism 2018;9(8).##Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci 2020;21(17):6275. ##Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y. Oxidative stress and diabetes: antioxidative strategies. Front Med 2020;14(5):583-600.##Goycheva P, Petkova-Parlapanska K, Georgieva E, Karamalakova Y, Nikolova G. Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications. Int J Mol Sci 2023;24(17):13541.##Leyane TS, Jere SW, Houreld NN. Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation. Int J Mol Sci 2022;23(13):7273. ##Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic Biol Med 2022;184:114-34. ##Ge T, Yang J, Zhou S, Wang Y, Li Y, Tong X. The Role of the Pentose Phosphate Pathway in Diabetes and Cancer. Front Endocrinol (Lausanne)  2020;11:365. ##Imam N, Alam A, Siddiqui MF, Veg A, Bay S, Khan MJI, et al. Network-medicine approach for the identification of genetic association of parathyroid adenoma with cardiovascular disease and type-2 diabetes. Brief Funct Genomics 2023;22(3):250-62.##Prasad S, DuBourdieu D, Srivastava A, Kumar P, Lall R. Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin. Int J Mol Sci 2021;22(13):7094.##Oliveira S, Monteiro-Alfredo T, Silva S, Matafome P. Curcumin derivatives for Type 2 Diabetes management and prevention of complications. Arch Pharm Res 2020;43(6):567-81.##Zhang HA, Kitts DD. Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases. Mol Cell Biochem 2021;476(10):3785-814. ##Slika H, Mansour H, Wehbe N, Nasser SA, Iratni R, Nasrallah G, et al. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother 2022;146:112442.##Shi G-J, Li Y, Cao Q-H, Wu H-X, Tang X-Y, Gao X-H, et al. In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature. Biomed Pharmacother 2019;109:1085-99.##Eid HM, Martineau LC, Saleem A, Muhammad A, Vallerand D, Benhaddou-Andaloussi A, et al. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol Nutr Food Res 2010;54(7):991-1003.##Pordzik J, Jakubik D, Jarosz-Popek J, Wicik Z, Eyileten C, De Rosa S, et al. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review. Cardiovasc Diabetol 2019;18(1):113. ##Wang Y, Zhou XY, Lu XY, Chen KD, Yao HP. Involvement of the circular RNA/microRNA/glucose-6-phosphate dehydrogenase axis in the pathological mechanism of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int  2021;20(6):530-4.##Wang L, Yuan Y, Li J, Ren H, Cai Q, Chen X, et al. MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network. Cell Stress Chaperones 2015;20(3):411-20.##Hu T, Chang Y-F, Xiao Z, Mao R, Tong J, Chen B, et al. miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD. Oncotarget 2016;7(52):86103-16. ##Pan JY, Sun CC, Bi ZY, Chen ZL, Li SJ, Li QQ, et al. miR-206/133b Cluster: A Weapon against Lung Cancer? Mol Ther Nucleic Acids 2017;8:442-9. ##Shan Z-X, Lin Q-X, Deng C-Y, Zhu J-N, Mai L-P, Liu J-L, et al. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett 2010;584(16):3592-600. ##Song JJ, Yang M, Liu Y, Song JW, Wang J, Chi HJ, et al. MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling. Eur J Pharmacol 2020;883:173374. ##Barajas JM, Reyes R, Guerrero MJ, Jacob ST, Motiwala T, Ghoshal K. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer. Sci Rep 2018;8:9105.##Wang R, Hong J, Cao Y, Shi J, Gu W, Ning G, et al. Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults. Eur J Endocrinol 2015;172(3):291-300. ##Pastukh N, Meerson A, Kalish D, Jabaly H, Blum A. Serum miR-122 levels correlate with diabetic retinopathy. Clin Exp Med 2019;19(2):255-60. ##Ding XQ, Gu TT, Wang W, Song L, Chen TY, Xue QC, et al. Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206. Mol Nutr Food Res 2015;59(12):2355-70.##Liu H, Wang L, Li F, Jiang Y, Guan H, Wang D, et al. The synergistic protection of EGCG and quercetin against streptozotocin (STZ)-induced NIT-1 pancreatic β cell damage via upregulation of BCL-2 expression by miR-16-5p. J Nutr Biochem 2021;96:108748.##Matboli M, Saad M, Hasanin AH, L AS, Baher W, Bekhet MM, et al. New insight into the role of isorhamnetin as a regulator of insulin signaling pathway in type 2 diabetes mellitus rat model: Molecular and computational approach. Biomed Pharmacother 2021;135:111176. ##Sivri D, Gezmen-Karadağ M. Effects of Phytochemicals on Type 2 Diabetes via MicroRNAs. Curr Nutr Rep 2024;13(3):444-54.##Bastos RVS, Dorna MS, Chiuso-Minicucci F, Felix TF, Fernandes AAH, Azevedo PS, et al. Acute green tea intake attenuates circulating microRNA expression induced by a high-fat, high-saturated meal in obese women: A randomized crossover study. J Nutr Biochem 2023;112:109203.##Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Mito S, Harima M, et al. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. Eur J Pharm Sci 2012;47(3):604-14.##Hwang S, Mruk K, Rahighi S, Raub AG, Chen C-H, Dorn LE, et al. Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator. Nat Commun 2018;9(1):4045. ##Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol 2019;11(3):45-63. ##Carette C, Dubois-Laforgue D, Gautier JF, Timsit J. Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: from one crisis to another. Diabetes Metab 2011;37(1):79-82. ##Xie T, Chen X, Chen W, Huang S, Peng X, Tian L, et al. Curcumin is a Potential Adjuvant to Alleviates Diabetic Retinal Injury via Reducing Oxidative Stress and Maintaining Nrf2 Pathway Homeostasis. Front Pharmacol 2021;12:796565.##Yang J, Miao X, Yang FJ, Cao JF, Liu X, Fu JL, et al. Therapeutic potential of curcumin in diabetic retinopathy (Review). Int J Mol Med 2021;47(5):75.##Mbese Z, Khwaza V, Aderibigbe BA. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers. Molecules 2019;24(23):4386.##Ren BC, Zhang YF, Liu SS, Cheng XJ, Yang X, Cui XG, et al. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways. J Cell Mol Med 2020;24(21):12355-67.##Pandima Devi K, Rajavel T, Daglia M, Nabavi SF, Bishayee A, Nabavi SM. Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer. Semin Cancer Biol 2017;46:146-57. ##Tumova S, Kerimi A, Williamson G. Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism. Free Radic Biol Med 2019;137:158-68.##Panchal HD, Vranizan K, Lee CY, Ho J, Ngai J, Timiras PS. Early Anti-Oxidative and Anti-Proliferative Curcumin Effects on Neuroglioma Cells Suggest Therapeutic Targets. Neurochem Res 2008;33(9):1701-10.##Yildirim H, Sunay FB, Sinan S, K&#246;&#231;kar F. In vivo effects of curcumin on the paraoxonase, carbonic anhydrase, glucose-6-phosphate dehydrogenase and β-glucosidase enzyme activities in dextran sulphate sodium-induced ulcerative colitis mice. J Enzyme Inhib Med Chem 2016;31(6):1583-90.##Singh G, Storey KB. MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease? Cells 2021;10(12):3374. ##Al‑Κafaji G, Al‑Muhtaresh HA, Salem AH. Expression and clinical significance of miR‑1 and miR‑133 in pre‑diabetes. Biomed Rep 2021;14(3):33.##Vinod M, Patankar JV, Sachdev V, Frank S, Graier WF, Kratky D, et al. MiR-206 is expressed in pancreatic islets and regulates glucokinase activity. Am J Physiol Endocrinol Metab 2016;311(1):E175-e85.##de Gonzalo-Calvo D, van der Meer RW, Rijzewijk LJ, Smit JWA, Revuelta-Lopez E, Nasarre L, et al. Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes. Sci Rep 2017;7(1):47.##Dahlmans D, Houzelle A, J&#246;rgensen JA, Phielix E, Lindeboom L, Hesselink MKC, et al. Evaluation of Muscle microRNA Expression in Relation to Human Peripheral Insulin Sensitivity: A Cross-Sectional Study in Metabolically Distinct Subject Groups. Front Physiol 2017;8(711).##Yildirim SS, Akman D, Catalucci D, Turan B. Relationship Between Downregulation of miRNAs and Increase of Oxidative Stress in the Development of Diabetic Cardiac Dysfunction: Junctin as a Target Protein of miR-1. Cell Biochem Biophys 2013;67(3):1397-408. ##Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011;4(4):446-54.##Wein SA, Laviano A, Wolffram S. Quercetin induces hepatic γ-glutamyl hydrolase expression in rats by suppressing hepatic microRNA rno-miR-125b-3p. J Nutr Biochem 2015;26(12):1660-3.##Akbari Kordkheyli V, Khonakdar Tarsi A, Mishan MA, Tafazoli A, Bardania H, Zarpou S, et al. Effects of quercetin on microRNAs: A mechanistic review. J Cell Biochem 2019;120(8):12141-55. ##Cui J, Pan Y, Wang J, Liu Y, Wang H, Li H. MicroRNA‑206 suppresses proliferation and predicts poor prognosis of HR‑HPV-positive cervical cancer cells by targeting G6PD. Oncol Lett 2018;16(5):5946-52.##Hu T, Chang YF, Xiao Z, Mao R, Tong J, Chen B, et al. miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD. Oncotarget. 2016;7(52):86103-16. ##Deng P, Li K, Gu F, Zhang T, Zhao W, Sun M, et al. LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis. Mol Med 2021;27(1):9. ##Wang L, Yuan Y, Li J, Ren H, Cai Q, Chen X, et al. MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network. Cell Stress Chaperones 2015;20(3):411-20.##Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L. Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep 2014;4(1):5150. ##Pastukh N, Meerson A, Kalish D, Jabaly H, Blum A. Serum miR-122 levels correlate with diabetic retinopathy. Clin Exp Med  2019;19(2):255-60.##Wang M, Zheng H, Zhou X, Zhang J, Shao G. miR-122 promotes diabetic retinopathy through targeting TIMP3. Anim Cells Syst (Seoul) 2020;24(5):275-81. ##Lee HM, Wong WKK, Fan B, Lau ES, Hou Y, O CK, et al. Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes. Sci Rep 2021;11(1):23756. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Swimming Exercise Attenuates DOX-Induced Cardiotoxicity by Modulating Apoptosis  and DRP1/PGC1α/ miR-23a Dependent Pathway in Rat Heart Tissue</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Doxorubicin (DOX) is a widely used drug in cancer chemotherapy, but its cardiotoxicity limits its clinical applications. Combining exercise with chemotherapy offers a promising approach to mitigate the side effects of chemotherapy drugs. Limited information is available on the effects of swimming exercise on the molecular mechanisms related to Dox cardiotoxicity. This study aims to investigate the modulatory effect of swimming exercise on the apoptosis and &lt;em&gt;miR-23a&lt;/em&gt;-dependent mitochondrial biogenesis and dynamics pathways in rat heart tissue treated with dox.&lt;em&gt; &lt;/em&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; In this experimental study, thirty-two adult male Wistar desert rats (200-220 &lt;em&gt;g&lt;/em&gt;) were randomly divided into four groups, including control, doxorubicin (DOX; intraperitoneal injection of 5 &lt;em&gt;mg/kg&lt;/em&gt; of Dox, once a week, for five weeks), swimming exercise (SE; water exercise for 60 &lt;em&gt;min&lt;/em&gt;/day, five days a week, for six weeks) and Dox group along with Swimming Exercise (DOX-SE). At the end of the study, the cardiac expression of proteins related to apoptosis and mitochondrial biogenesis and &lt;em&gt;mir23-a&lt;/em&gt; were analyzed using western blot and real-time PCR methods, respectively. One-way analysis of variance (ANOVA)with Tukey&amp;#39;s post hoc test was used to analyze the data.&lt;em&gt; &lt;/em&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; These findings revealed that DOX administration led to a significant decrease in the cardiac expression of PGC-1&amp;alpha; and DRP-1 proteins and an increase in apoptotic proteins (caspase 3 and cytochrome C) compared to the control group (p&amp;lt;0.0001). Swimming exercise resulted in a significant increase expression in cardiac tissue of PGC-1&amp;alpha; and DRP-1 proteins and a decrease in the expression of apoptotic proteins in the DOX-treated group (p&amp;lt;0.0001, p&amp;lt;0.01). Compared to the control group, the protein levels in the heart of the &lt;em&gt;miR-23a&lt;/em&gt; were significantly increased in the DOX-treated group (p&amp;lt;0.001). However, exercise training attenuated the DOX-induced reduction in &lt;em&gt;miR-23a&lt;/em&gt; expression gene in the cardiac muscle of DOX-treated mice (p&amp;lt;0.05).&lt;em&gt; &lt;/em&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; These findings suggest that swimming exercise may protect against DOX-induced cardiotoxicity by regulating apoptosis and DRP1/PGC1&amp;alpha;/ miR-23a&lt;em&gt; &lt;/em&gt;pathway. This highlights exercise as a potential non-pharmacological strategy to mitigate chemotherapy-related heart damage.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>225</FPAGE>
            <TPAGE>232</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Hassan</Name>
<MidName></MidName>
<Family>Darvakh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Shohadayehoveizeh Campus of Technology, Shahid Chamran University of Ahvaz</Organization>
</Organizations>
<Universities>
<University>Shohadayehoveizeh Campus of Technology, Shahid Chamran University of Ahvaz</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Saied</Name>
<MidName></MidName>
<Family>Shakerian</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Rohollah</Name>
<MidName></MidName>
<Family>Ranjbar</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Sport Physiology, Faculty of Sport Science, Shahid Chamran University of Ahvaz</Organization>
</Organizations>
<Universities>
<University>Department of Sport Physiology, Faculty of Sport Science, Shahid Chamran University of Ahvaz</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad reza</Name>
<MidName></MidName>
<Family>Tabandeh </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Basic, Science, Division of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz</Organization>
</Organizations>
<Universities>
<University>Department of Basic, Science, Division of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Apoptosis</KeyText></KEYWORD><KEYWORD><KeyText>Cardiotoxicity</KeyText></KEYWORD><KEYWORD><KeyText>Doxorubicin</KeyText></KEYWORD><KEYWORD><KeyText>Swimming</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>70622.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Lee Y, Kwon I, Jang Y, Cosio-Lima L, Barrington P. Endurance Exercise Attenuates Doxorubicin-induced Cardiotoxicity. Med Sci Sports Exerc 2020 Jan;52(1):25-36.##Chen R, Niu M, Hu X, He Y. Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity. Front Mol Biosci 2023 Aug 3;10:1241225. ##Kciuk M, Gielecińska A, Mujwar S, Kołat D, Kałuzińska-Kołat Ż, Celik I, et al. Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity. Cells 2023 Feb 19;12(4):659.##Ding Q, Qi Y, Tsang SY. Mitochondrial Biogenesis, Mitochondrial Dynamics, and Mitophagy in the Maturation of Cardiomyocytes. Cells 2021 Sep 18;10(9):2463. ##Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther 2023 Sep 6;8(1):333. ##Zerihun M, Sukumaran S, Qvit N. The Drp1-Mediated Mitochondrial Fission Protein Interactome as an Emerging Core Player in Mitochondrial Dynamics and Cardiovascular Disease Therapy. Int J Mol Sci 2023 Mar 17;24(6):5785.##Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Ther 2024 Mar 1;9(1):50.##You W, Knoops K, Berendschot TTJM, Benedikter BJ, Webers CAB, Reutelingsperger CPM, et al. PGC-1a mediated mitochondrial biogenesis promotes recovery and survival of neuronal cells from cellular degeneration. Cell Death Discov 2024 Apr 17;10(1):180.##Du J, Hang P, Pan Y, Feng B, Zheng Y, Chen T, et al. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway. Toxicol Appl Pharmacol 2019 Apr 15;369:73-81.##Zou R, Wang S, Cai H, Wang Y, Wang C. Pharmacological Activation of Rev-erbα Attenuates Doxorubicin-Induced Cardiotoxicity by PGC-1α Signaling Pathway. Cardiovasc Ther 2023 Feb 22;2023:2108584. ##Bikomeye JC, Terwoord JD, Santos JH, Beyer AM. Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress. Am J Physiol Heart Circ Physiol 2022 Oct 1;323(4):H702-H720.##Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, et al. MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Target Oncol 2020 Jun;15(3):261-278.##Zhao L, Qi Y, Xu L, Tao X, Han X, Yin L, Peng J. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol 2018 May;15:284-96.##Chen R, Niu M, Hu X, He Y. Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity. Front Mol Biosci 2023 Aug 3;10:1241225. ##Gaytan SL, Lawan A, Chang J, Nurunnabi M, Bajpeyi S, Boyle JB, et al. The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity. Front Physiol 2023 Mar 9;14:1133423. ##Alharbi I, Alharbi H, Almogbel Y, Alalwan A, Alhowail A. Effect of Metformin on Doxorubicin-Induced Memory Dysfunction. Brain Sci 2020 Mar 7;10(3):152.  ##Poursadeghi S, Kashef M, Shahidi F. The effect of water aerobic exercise on the expression of Apaf-1, cytochrome C and Caspase-9 genes of cardiomyocyte tissue in male rats poisoned with hydrogen peroxide. Journal of Practical Studies of Biosciences in Sport 2023 Mar 21;11(25):68-77.##Tabandeh MR, Jozaie S, Ghotbedin Z, Gorani S. Dimethyl itaconic acid improves viability and steroidogenesis and suppresses cytokine production in LPS-treated bovine ovarian granulosa cells by regulating TLR4/nfkβ, NLRP3, JNK signaling pathways. Res Vet Sci 2022 Dec 20;152:89-98.##Wang T, Xing G, Fu T, Ma Y, Wang Q, Zhang S, et al. Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies. Int J Med Sci 2024 Mar 11;21(5):809-16.##Singh H. Mitochondrial ion channels in cardiac function. Am J Physiol Cell Physiol 2021 Nov 1;321(5):C812-C825.##Liu BH, Xu CZ, Liu Y, Lu ZL, Fu TL, Li GR, et al. Mitochondrial quality control in human health and disease. Mil Med Res 2024 May 29;11(1):32.##Abu Shelbayeh O, Arroum T, Morris S, Busch KB. PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel) 2023 May 10;12(5):1075. ##Sui YB, Xiu J, Wei JX, Pan PP, Sun BH, Liu L. Shen Qi Li Xin formula improves chronic heart failure through balancing mitochondrial fission and fusion via upregulation of PGC-1α. J Physiol Sci 2021 Oct 18;71(1):32.##Shipra, Tembhre MK, Hote MP, Bhari N, Lakshmy R, Kumaran SS. PGC-1α Agonist Rescues Doxorubicin-Induced Cardiomyopathy by Mitigating the Oxidative Stress and Necroptosis. Antioxidants (Basel) 2023 Sep 5;12(9):1720.##Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight 2020 May 7;5(9):e132747.##Wang K, Zhu Q, Liu W, Wang L, Li X, Zhao C, et al. Mitochondrial apoptosis in response to cardiac ischemia-reperfusion injury. J Transl Med 2025 Jan 28;23(1):125.##Wang H, Zhang C, Li M, Liu C, Wang J, Ou X, Han Y. Antimicrobial Peptides Mediate Apoptosis by Changing Mitochondrial Membrane Permeability. Int J Mol Sci 2022 Oct 22;23(21):12732. ##Zhao D, Sun Y, Tan Y, Zhang Z, Hou Z, Gao C, et al. Short-Duration Swimming Exercise after Myocardial Infarction Attenuates Cardiac Dysfunction and Regulates Mitochondrial Quality Control in Aged Mice. Oxid Med Cell Longev 2018 Apr 11;2018:4079041. ##Ng R, Hussain NA, Zhang Q, Chang C, Li H, Fu Y, et al. miRNA-32 Drives Brown Fat Thermogenesis and Trans-activates Subcutaneous White Fat Browning in Mice. Cell Rep 2017 May 9;19(6):1229-1246.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

    </ARTICLES>
  </JOURNAL>
</XML>
